In addition, high Dickkopf-1 (DKK1), an inhibitor of the Wnt/β-catenin signaling pathway, in NSCLC was linked with the proliferative and invasive capacity, and it could be a potential therapeutic target (51). The gene discussed is DKK1; the disease is non-small cell lung carcinoma.